Annette Snejbjerg Bartels

Annette Snejbjerg Bartels

Biomedical Laboratory Scientist


Publication year:
All
1 - 10 out of 15Page size: 10
Sort by: 1st author
  1. Published

    Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer: A Danish Breast Cancer Cooperative Group Study

    Willemoe, G. L., Hertel, P. B., Bartels, Annette Snejbjerg, Jensen, M., Balslev, E., Rasmussen, B. B., Mouridsen, H. T., Ejlertsen, Bent Laursen & Brunner, N., 2009, In: European Journal of Cancer. 45, 14, p. 2528-2536 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue

    Usher, P. A., Sieuwerts, A. M., Bartels, Annette Snejbjerg, Lademann, U., Nielsen, H. J., Holten-Andersen, L., Foekens, J. A., Brünner, N. & Offenberg, H. K., 2007, In: Molecular Oncology. 1, 2, p. 205-215 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node

    Tvedskov, T. F., Bartels, Annette Snejbjerg, Jensen, M., Paaschburg, B., Kroman, N., Balslev, E. & Brünner, N., 2011, In: APMIS Supplementum. 119, 12, p. 844-852 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer

    Steffensen, K. D., Waldstrøm, M., Christensen, R. K., Bartels, Annette Snejbjerg, Brunner, N. & Jakobsen, A., 2010, In: BMC Cancer. 10, 185, 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?

    Munro, A. F., Bartels, Annette Snejbjerg, Balslev, E., Twelves, C. J., Cameron, D. A., Brünner, N. & Bartlett, J. M., 2013, In: Breast Cancer Research (Online Edition). 15, 2, 8 p., R31.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome

    Jensen, S. A., Vainer, B., Bartels, Annette Snejbjerg, Brünner, N. & Sørensen, Jens Benn, 2010, In: European journal of cancer (Oxford, England : 1990). 46, 18, p. 3233-42 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - associations with histopathology and patients outcome

    Jensen, S. A., Vainer, B., Bartels, Annette Snejbjerg, Brunner, N. & Sørensen, J. B., 2010, In: European Journal of Cancer. 46, 18, p. 3233-3242 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells

    Høeberg, M., Noer, Julie Boertmann, Vistesen, M. V., Bartels, Annette Snejbjerg, Bech, E. M., Nygård, S. B., Lademann, U., Stenvang, Jan, Liu, S., Fuglsang, Anja Thoe, Brünner, N. & Moreira, José, 2023, In: Molecular Oncology. 17, 8, p. 1595-1612

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients

    Hertel, P. B., Tu, D., Ejlertsen, Bent Laursen, Jensen, M. R., Balslev, E., Jiang, S., O'Malley, F. P., Pritchard, K. I., Shepherd, L. E., Bartels, Annette Snejbjerg, Brunner, N. & Nielsen, T. O., 2012, In: Breast Cancer Research and Treatment. 132, 1, p. 225-234 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial

    Erber, R., Gluz, O., Brünner, N., Kreipe, H. H., Pelz, E., Kates, R., Bartels, Annette Snejbjerg, Huober, J., Mohrmann, S., Moustafa, Z., Liedtke, C., Möbus, V., Augustin, D., Thomssen, C., Jänicke, F., Kiechle, M., Kuhn, W., Nitz, U., Harbeck, N. & Hartmann, A., Apr 2015, In: Breast Cancer Research and Treatment. 150, 2, p. 279-288 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 6090964